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INTRODUCTION 
 
   Liver abscess is a common condition in India. India has 2nd highest incidence 
of liver abscess in the world. Liver abscesses are caused by bacterial, parasitic and 
fungal infection. 
 
  Pyogenic abscesses account for three fourth of hepatic abscess in developed 
countries. While amoebic liver abscess cause two third of liver abscess in developing 
countries2. 
 
 Amoebiasis is now the third most common cause of death from parasitic disease. 
 
   The World Health Organisation reported that Entamoeba Histolytica causes 
approximately 50 million cases and 100,000 deaths annually.3 The vast majority of 
these infections are all acquired in the developing world. In a country like India, 
majority of population lives below poverty line, basic sanitary facilities are lacking. 
This coupled with overcrowding, urban slums and also outdoor unhygienic eating 
habits sets the stage for communicable diseases like amoebiasis. 
 
  Liver abscess continues to be condition with considerable mortality in our 
country. 
 
   Locally made alcoholic drinks like arrack may be the routes of faeco-oral 
transmission of amoebic cysts. 
 
   Primary prevention by improving sanitation, health education, early diagnosis 
and prompt treatment may result in lowering mortality / morbidity associated with the 
disease. 
 
 This study has tried to delineate clinical profile, risk factors and management 
strategies of liver abscesses. 
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AIM AND OBJECTIVES OF STUDY 
 
          1) To correlate incidence of liver abscess in Alcoholic  and non alcoholic Patients. 
 
          2) spectrum of clinical presentations. 
 
          3) To evaluate the efficacy of ultrasonography. 
 
         4) To assess outcome of various treatment
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REVIEW OF LITERATURE 
 
♣ AMOEBIC LIVER ABSCESS 
 
HISTORY 
 
  The first mention of blood and mucus diarrhea is found in the Sanskrit 
document Bhrigu-samhita, dated 3000 BC.4 The association of ‘ball-like’ 
abdominal masses with this condition has also been recorded and is thought to 
be indicative of co-existing hepatic abscess. 
 
   The occurrence of a similar syndrome in different parts of the world is 
recorded in the writings of Hippocrates (5th century BC), Roman 
physicians, and practitioners in the middle ages.5 
 
   Open drainage of liver abscesses with insertion of setons into the 
abscess cavity were advocated by Ballingall, but the technique fell into 
disrepute because it is highly associated mortality due to sepsis. Twenty-six 
such tropical abscesses in association with dysentery were described in series 
of autopsy  in 1828 by Amesley in Bombay.2 
 
   In his 1875 a case report describing a fatal case of amoebic colitis in a 
Russian peasant who had migrated to St. Peterburg from within the Arctic 
circle, Lesch found motile amoebae in the mucus clots of his patient’s faeces 
and demonstrated during autopsy that the terminal ileum and colon had 
submucosal invasion by amoeba.5 
 
   Medical treatment for amoebic colitis has been described since ancient 
times. A plant alkaloid called concessine was advocated in the Ayurveda, has 
been found to kill E. histolytica in culture. 
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♣ EMBRYOGENESIS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Differentiation (vertical arrows) and induction (horizontal arrows) in the  
development of liver cords and sinuses in the embryo. 
 
 
1. The earliest appearance of the liver primordium occurs on Day 22 after conception. 
Day 24, the hepatic diverticulum is growing into the transverse septum. 
2. The vitelline and umbilical veins divide into a plexus of vessels, and the 
invading endoderm cells move into these spaces around and between them. 
3. Day 32, most of the blood flow from the umbilical veins has been trapped by the 
parenchyma that surrounds the venous channels which later become the liver 
sinusoids. 
4. The right umbilical vein regresses in the sixth week. The left vein carries placental 
blood to the fetus upto birth. 
5. Day 51, the intrahepatic veins have nearly attained the normal adult distribution and 
segmentation. 
6. Growth of the liver makes it to bulge out of the transverse septum so that the 
liver becomes a truly abdominal organ lying in the ventral mesentery. 
7. The intrahepatic bile ducts are believed to differentiate from hepatic cells and join the 
extrahepatic duct system secondarily. 
8. By the ninth week, the liver embraces as much as 10% of body volume. Its 
relative size decreases to 5% by term. 
9. Initially  the left lobe is larger than right lobe. Between birth and adulthood, the 
right lobe increases in size at the expense of the left lobe, which undergoes some 
peripheral degeneration. 
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♣ ANATOMY OF LIVER: 
 
• Liver is a large, solid, wedge shaped gland which occupies entire  right 
 
hypochondrium, the greater part of the epigastrium and part of the left 
 
hypochondrium upto the left lateral plane. 
 
• It is the largest gland of the body and contributes to 2% of the total body weight. 
 
• Weighs 1.6kg in male and 1.3kg  in female 
 
• It has five surfaces: 
 
 
 Anterior 
 
 Posterior 
 
 Superior 
 
 Inferior and 
 
 Right  
 
• It is divided into right and left lobe anteriorly by falciform ligament  and superiorly, 
by the fissure of ligamentum teres, inferiorly  by the fissure for ligamentum venosum 
posterioly. 
• Right lobe is very much larger than the left lobe and forms five sixth of the liver  and 
also presents the caudate and quadrate lobe. 
 
• Porta hepatis is a deep , transverse fissure situated on the inferior surface of the right 
lobe. 
 
• Portal vein , the hepatic artery and  hepatic plexus of nerves enter the liver through the 
porta hepatis while right and left hepatic ducts and few lymphatics leave it. 
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HEPATIC SEGMENTS 
 
 
¾ On the basis of intrahepatic distribution of the hepatic artery, portal vein and biliary 
ducts, liver is divided into right and left hemilivers by Cantlie’s Line. 
¾ Further divided into total of eight segments i.e. Couinauds Segments. 
¾ Each segments have their own hepatic artery branch and biliary tree. 
 
BLOOD SUPPLY: 
 
  Blood flow  is 25% of total cardiac output. 
 
  80%  is derived from portal vein. 
 
  20% is derived from hepatic artery. 
 
  Before entering the liver both hepatic artery and portal vein divide into right 
and left branches. 
 
  Within the liver they redivide into segmental vessels, which further divide to 
form interlobular vessels, which run in portal canals. 
LYMPHATICS OF LIVER 
 
 
 Superficial lymphatics terminate in: 
 
¤ Caval 
 
¤ Hepatic 
 
¤ Paracardial and 
 
¤ Coeliac lymph node. 
 
 
 Deep lymphatics terminate in: 
 
¤ Supra diaphragmatic and 
 
¤ Hepatic lymph node. 
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NERVE SUPPLY 
 
• Liver receives its nerve supply from hepatic plexus which contains 
both sympathetic and parasympathetic( vagal plexus). 
 
HISTOLOGY: 
 
• Each segment is made up of a multiple smaller units known as hepatic lobule. 
 
• Each lobule appears to be made up of cords of liver cells that is separated by 
sinusoids. 
 
• Along the periphery of each lobule, there are portal canals. 
 
• Each portal canal contains: 
 
a) A branch of the portal vein 
 
b) A branch of the hepatic artery 
 
c) An interlobular bile duct. 
 
• These three structures collectively form a portal triad. 
 
 
• Blood from the branch of the portal vein and from the branch of the hepatic 
artery, enterthe sinusoids at the periphery of the lobule and passes towards its 
centre. 
 
• Here the sinusoids open into a central vein that occupies the centre of the 
lobule. 
 
• In contrast, the flow of bile is in the opposite direction along the biliary 
canaliculi into the terminal bile ductules and subsequently into the interlobular 
bile ducts located in the portal tracts. 
 
• The sinusoids are lined by an endothelium in which there are numerous pores. 
 
• Interspersed amongst the endothelial cells there are hepatic macrophages i.e 
kupffer cells. 
 
• The surface of the liver cell are separated from the endothelial lining of the 
sinusoid by a narrow perisinusoidal space of disse, which contains stellate 
cells. 
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• These stellate cells play a vital role in the storage and metabolism of vitamin 
A and are transformed into collagen producing myofibroblasts when there is 
inflammation of the liver 
 
 
 
  TABLE 1 : PHYSIOLOGICAL FUNCTIONS OF LIVER:  
 
 
 
 
Principal Functions of the Liver. 
 
1. Formation and secretion of bile 
 
2. Nutrient and vitamin metabolism 
 
a. Glucose and other sugars 
 
b. Amino acids 
 
c. Lipids 
 
d. Fatty acids 
 
e. Cholesterol 
 
f. Lipoproteins 
 
g. Fat-soluble vitamins 
 
h. Water-soluble vitamins 
 
3. Inactivation of various substances 
 
a. Toxins 
 
b. Steroids 
 
c. Other hormones 
 
4. Synthesis of plasma proteins 
 
a. Acute-phase proteins 
 
b. Albumin 
 
c. Clotting factors 
 
d. Steroid-binding and other hormone-binding 
proteins 
 
5. Immunity  
a. Kupffer cells  
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  TABLE 2 : TESTS OF LIVER FUNCTION 
 
TESTS FUNCTION 
  
Serum Bilirubin Uptake, conjugation, and excretion of bile 
  
Serum Alkaline Phosphatase Cholestasis and biliary obstruction 
  
Serum GGT Cholestasis and biliary obstruction, 
 alcohol use 
  
Transaminases (AST and ALT) Hepatocyte Necrosis 
  
Prothrombin Time Protein Synthesis 
  
Albumin Protein Synthesis 
  
Aminopyrine Breath Test Microsomal function 
  
Antipyrine clearance Microsomal function 
  
Caffeine clearance Microsomal function 
  
Lidocaine clearance Microsomal function 
  
Galactose elimination capacity Cytosolic function 
  
Indocyanine Green Clearance Hepatic perfusion and anion excretion 
  
Sulfobromopthalein clearance Hepatic perfusion and anion excretion 
  
Tc-GSa scan Function hepatocyte mass 
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EPIDEMIOLOGY  
 
   Worldwide, amoebiasis is the 3rd  most common parasitic cause of 
death.9 It is classically defined as infection with E. histolytica with or without 
overt clinical symptoms. E. histolytica was thought to be ubiquitous in 
distribution in both the temperate and tropical countries with an estimated 
12% global incidence of infection. 
 
   It is now recognized that a number of these individuals may harbour E. 
dispar and not E.histolytica. Together these two organisms are now thought to 
infect 10% of the world’s population, with E. dispar infection being 10-fold 
more common than E. histolytica. 
   Among those infection with E. histolytica, 50 million persons develop 
invasive amebiasis (colitis and hepatic abscess) resulting in 1,00,000 deaths 
annually (1985).3 
 
   High risk groups include immigrants and travelers from endemic 
zones, residents of institutions-especially mentally retarded individuals, , low 
socioeconomic groups and male promiscuous homosexuals. It may be 
important to note that here traveler’s diarrhea is rarely caused by E. histolytica, 
which usually occurs only after a long stay – usually over 1 month in an 
endemic area. Furthermore, the observation, that male homosexuals despite a 
high incidence of infection; may rarely get invasive disease in temperate 
climates is probably because of the usual organism harboured is the 
morphologically indistinguishable E. dispar.10 
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PYOGENIC LIVER ABSCESS  
 
Incidence 
 
   In 1938, Ochsner and DeBakey published what was then the largest 
series of pyogenic abscess in the literature about 139 cases of amoebic abscess 
and 47 cases of pyogenic abscess. 
 
   Pyogenic liver abscess (PLA) was seen to be a affecting young 
patients, predominately with pyelophlebitis secondary to a acute appendicitis. 
If left untreated, this condition was invariably become fatal. The median age of 
patients with PLA was found to be the third decade. Many subsequent series 
have been  describing the changes in the clinical patterns of hepatic abscess. 
 
  With the effective treatment of such conditions (appendicitis, other acute 
colonic diseases), there had been a shift in the aetiology and age distribution 
of patients presenting with hepatic abscess. 
 
   Numerous studies have also subsequently reported biliary tract disease 
to be the most frequent underlying lesion associated with PLA, with a peak 
incidence in the seventh and eight decades .11,12 
 
   Studies from postmortem series have been constant. An early report in 
1901 recorded an incidence of 0.45% among 17204 autopsies (Kobler 1901) 
whereas a similar series in 1960 showed an incidence of 0.59%.11 
 
   The reduction of pyelophlebitis related PLA would account for a 
proportional increase in the numbers of cryptogenic PLA. However, it remains 
possible that there has been a recent true increase in the incidence of primary 
cryptogenic PLA.9,13 
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 ETIOPATHOGENESIS:  
 
AMOEBIC LIVER ABSCESS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 : E.histolytica Cycle 
 
The organism 
 
   The protozoan E. histolytica belongs to  subphylum Sarcodina (whose 
motility depends on pseudopodia), the supercalss Rhizopoda and the order 
Amoebida. 
 
   The genus Entamoeba includes the species E. histolytica, E. bartmanni 
(a noninvasive ‘small race’ with cysts <10 um in diameter), Entamoeba. coli, 
E.polecki (infects pigs) and E. moshkovski (a free-living non-pathogenic form 
which isfound in sewage). 
   Except for E. histolytica, the other species are considered as non-
pathogenic. 
 
  With the discovery of E. dispar, the identification of E. histolytica on 
morphology has become unreliable. 
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   The presence of ingested erythrocytes is seen only with E. histolytica. 
 
  The two species have now been characterized by the study of zymodemes 
(patterns of electrophoretic mobility of isoenzymes) and the genetic 
differences using RNA and DNA probes, and the use of polymerase chain 
reaction amplification. 
 
   E. histolytica has two forms : Trophozoite and cyst. The trophozoites 
areuninucleate, facultative anerobes with a double-layered limiting membrane 
surrounded by a fuzzy, external 20-30  m glycocalyx. With the emerging 
concepts of virulence, it appears that only certain strains of E. histolytica are 
capable of tissue invasion and contact lysis of cells.14 
 
   Cysts of E. histolytica are quadrinucleate. These cysts, measuring 8-
20mm, are an important identifying feature, and constitute the infective form 
of the organism. 
 
   They are responsible for the faecal-oral transmission via food, water or 
direct person-to-person contact. 
 
   After ingestion, the quadrinucleate cysts reach the intestinal tract, 
where they develop into a metacystic stage and undergo an additional nuclear 
division; thus, eight new uninucleate trophozoites emerge to complete the life 
cycle. 
 
   Cysts survive up to 45 minutes in faecal material lodged under the 
finger-nails and up to 1 month in soil at 10oC. They remain infective in fresh 
water, sea water and sewage but are rapidly destroyed by drying, 200 p.p.m. of 
iodine and heat above 68oC. These are not killed by chlorination used to 
purify ordinary drinking water.15 
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TABLE – 3 : DISTINGUISHING FEATURES OF VIRULENT AND NON-
VIRULENT AMOEBAE 
Characteristics Virulent strains Non-virulent strains 
   
Size (um) 20 - 60 (um) 7 – 30(um) 
   
Negative surface charge Less More 
   
Concanavalin A receptors Present Absent 
   
Effect of PMNs and tissue Lethal 3000 PMNs/Eh Susceptible to PMNs 
culture cells   
   
Human serum complement Resistant Susceptible 
   
 
 
Host factors 
 
   The human host represents the major reservoir although cross-infection from 
animals particularly monkeys and rodents has been postulated. Interperson 
transmission occurs via files and handles, and by sewage contamination of water 
sources. Male homosexuals also transmit the disease, but usually harbour non-
pathogenic E. dispar. 
 
   Again, for the reasons not completely understood, menstruating women are 
protected against invasive infection. Breast-fed children also have a low incidence 
of invasion, and this has been postulated to be due both to the presence of 
protective IgA in the immune mother’s milk and to the low iron content of milk. 
  Elderly individuals with the underlying diseases, and patients with depressed 
immunity due to malnutrition or corticosteroid therapy, are also prone to invasion 
by amoebae. 
   The natural resistance of menstruating women is lost in pregnancy.15 
 
   In Mexican Mestizo population the presence of HLA DR3 and complement 
type SCO1 in both adults and children constitutes the primary independent risk 
factor for the development of amoebic liver abscess, irrespective of the age or sex. 
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PATHOGENESIS  
 
   E. histolytica reaches  the liver via the portal blood-evidence for 
directextension and spread along lymphatics being lacking. 
  Agent-host interactions resulting in the production of such large abscesses are 
postulated to be due to: Infarction, Enzymatic hydrolysis, and Immunological 
reactions. 
 
   While small infarcts due to small vessel occlusion by amoebae have 
been demonstrated, these may only be very early lesions.16 
   Cell-free extracts of E. histolytica are known to contain material toxic 
to mammalian cells, and include proteases, glycosidases, phospholipase, 
hemolysins and a pore forming protein. 
   However, enzymatic hydrolysis, probably one of  the major mechanism 
involved, occurs not because of released exotoxin by the amoebae, but owing 
to a more complex sequence of events. All the  amoebic enzymes are inhibited 
by serum and they require direct contact to exert any effect on host tissue. 
Adherence, followed by cytolysis, is followed in turn by amoebic phagocytosis 
of the dead target cell. A current hypothesis of amoebic contact-development 
cytolysis is as follows:17 
   Amoebae adhere to target cells by means of an adhesin. These 
compounds are soluble lectins they  are susceptible to inhibition by N-acetyl-
D-galactosamine. 
 
   Adherence initiates a calcium ion-dependent membrane perturbation 
and amoebic microfilament function. Amoebic phospholipase A is activated 
first. 
 
   Amoebic lyso compounds toxic to cell membranes are then released. 
The poreforming protein, which acts on cells in a manner akin to complement, 
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and finally results in colloid osmotic lysis of the cell, may be the final toxic 
Immunological reactions to E. histolytica are both cellular and humoral. While 
it has not been finally established as to which one is responsible for limiting 
invasion by amoebae, immunity against recurrent disease does develop. In 
Amoebic liver abscess Recurrence is very rare-with only 0.29% recurrence 
among 1021 patients followed for 5 years in Mexico.17 
 
   Among the various humoral mechanisms,the most important is the 
natural protection afforded by circulating complement. E. histolytica is 
susceptible to complement in the serum of both healthy and immune 
individuals. However, complement, cannot prevent invasion, as it is not 
present in gut mucosal secretions. Also, strains resistant to complement 
develop over time when exposed in vitro, and complement resistance – 
probably mediated by a 170kD submit of the adhesive lectin – one of the 
characteristic features of the pathogenic zymodemes. 
 
   Between 81% to 100% of patients with invasive colonic amoebiasis 
develop specific circulating IgG antibodies, and this response lasts for 2-11 
years. There is, however, no positive correlation between this response and 
invasive infection. 
   Amoebae have been shown to aggregate, ingest and shed human 
antibodies,and invasive amoebiasis can occur in the presence of high titres.14 
 
  Similarly, among the cellular mechanisms, neutrophils are particularly very 
much ineffective against E. histolytica, and are immediately lysed by the 
virulence of the parasite. This  result in the release of toxicenzymes of 
neutrophil and such enzymes may further increase the local tissue destruction 
in amoebic liver abscess. 
17 
 
 
 
  
   There is an experimental evidence that liver cell necrosis is increased 
when neutrophils are present along with E. histolytica. 
 
   Lymphocytes and macrophages appear to be the important effector 
cells with activity against E. histolytica, the evidence being : 
 
1. Lymphocytes (and lymphocyte supernatants) from patients recently cured 
of amoebic liver abscess are cytotoxic to amoebic trophozoites. 
Lymphocytes from normal controls are, however, phagocytosed by 
E.histolytica. 
2. Antimacrophage and antilymphocytes globulin,  splenectomy,neonatal 
thymectomy and steroid therapy results in enhanced formation of amoebic 
liver abscesses in animal models. 
3. Non-specific activators like concanavalin A (a classic T cell mitogen) and 
phytohaemagglutinin appear to activate the macrophages, in contrast to 
immune serum, thereby indicating an antibody-independent process. 
 
4. Both oxidative and non-oxidative effector mechanisms of macrophages are 
operative in the destruction of amoebae. 
5. Lymphocytes of the T cells phenotype T8 are responsible for amoebicidal 
activity. 
   Amoebic protein is capable of causing a marked T cell proliferative 
response similar to concanavalin A, and appears to be important in the afferent 
limb of cell mediated immunity. 
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PATHOLOGY:  
 
   Irrespective of the mechanism involved, liver cells will undergo liquefaction 
necrosis starting in the centre and then spreading to peripherally and produce a cavity 
filled with blood and liquefied liver tissue. The appearance of this pus is typically 
described as like ‘anchovy sauce’, and it has no odour. Secondary infectionoccurs 
very rarely  spontaneously, but may changethe consistency and  colour of the pus, and 
certainly its odour too. With centrifugal extension the abscess soon comes to lie just 
adjacent to Glisson’s capsule, which is resistant to the amoebae. Similarly, the abscess 
cavity is criss-crossed by  biliary portal and vascular structures which, because of their 
intrahepatic covering of Glisson’s capsule, are resistance to the process of liquefaction 
necrosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 : Variable appearance of fluid aspirated from a single amoebic liver abscess.  
Far left: initial aspirate, straw coloured but tinged with bile. Middle: mid aspirate 
creamish in color. Far right: typical ‘Anchovy sauce’ from terminal aspirate. 
 
 
 Amoebae are identifiable in the spreading margin of the abscess, and under the 
capsule. The abscess wall is typically ill-defined with a minimal host response of 
fibrous tissue. Mature abscess may, however develop a fibrous wall and may even 
calcify. In the completely treated case, complete resolution is the rule, but may take 
longer time between 6 months to 2 years – longer usually than the time for pyogenic 
abscesses to resolve.18 
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PYOGENIC LIVER ABSCESS  
 
Etiology 
 
   Pyogenic liver abscess results from bacterial infection of the liver parenchyma and 
subsequent infiltration, with an area of hepatic necrosis may result. Even if these areas 
are initially sterile, bacterial seeding may subsequently occur resulting in the formation 
of liver abscess. There may also be a much significant delay between the initial trauma 
and the development of liver abscess, thereby adding to the diagnostic difficulty. Liver 
abscess may also coexist with other forms of hepatic injury, for example; arterial 
pseudoaneurysm. A very high index of suspicion is therefore required, together with an 
high awareness of the other possible complications of liver trauma.19 
 
   In all series, there remain a group of patients where no underlying cause of liver  
abscess in identified. In recent series such as cryptogenic abscesses have accounted for 
between 20 and 45% of hepatic abscess.9,20. By definition, these patients have usually 
undergone abdominal USG and CT. Computed tomography in particular has a very 
high sensitivity for abdominal mass lesions associated with intraabdominal sepsis. It 
therefore seems unlikely that unrecognized biliary tact disease or other sources of 
intra-abdominal sepsis could account for cryptogenic PLA. A many number of possible 
mechanisms have been proposed to account for the formation of cryptogenic liver 
abscess. 
 
   These include the failure to diagnose or the resolution of an infective process within 
the abdomen, spontaneous intrahepatic thrombosis and infarction, unrecognized 
trauma or the presence of unrecognized hepatic cysts or hydatid disease. Portal 
infection is then thought to result in bacterial seeding and the generation of hepatic  
abscess.22 
 It has been suggested that all the patients with a diagnosis of cryptogenic liver 
abscess should undergo full biliary and gastrointestinal evaluation. However, in the 
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absence of any specific symptoms or signs, data from recent series would not 
appear to support this view. 
 
   Branum et al (1990)13 performed open surgical drainage in 16 of 20 patients 
with cryptogenic liver abscess. Despite full operative evaluation, there remained no 
identified cause for hepatic abscess in each of these patients. 
 
   The etiology of pyogenic liver abscess may be categorized according to 
the route by which infecting organisms gain access to the liver. Hepatic abscess 
may arise as the result of biliary obstruction and subsequent cholangitis. This may 
result in  formation of single or multiple macroscopic abscess collections. Acute 
suppurative cholangitis is a condition that generally associated with small, multiple 
and bilateral abscesses reflecting the uniform distribution of infecting organisms 
throughout the biliary tree. 
 
  Ascending infection via the biliary system is now the single most identified 
cause of pyogenic liver abscess, accounting for approximately one-half of all 
cases.23,24 
 
  Liver  abscess may also occur following biliary tract surgery, particularly 
procedures that involve biliary enteric anastomosis. 25 
 
   Portal vein pyelophlebitis is now a very less frequent identified cause 
of liver abscess, though this may still account for up to 20% of cases. The primary 
sources of such abscesses include, pancreatitis, inflammatory bowel disease, acute 
diverticulitis, perforated viscus or any other source of intra-abdominal or pelvic 
abscess. In the neonatal period, liver abscess may occur following umbilical vein 
sepsis. 
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  TABLE 4 : THE ETIOLOGY OF PYOGENIC LIVER ABSCESS HUANG ET 
AL 1996 CHU ET AL 199620 
 Huang et al 1996 
Chu et al 
1996 
    
 1952-1972 1973-1993 1984-1995 
 (n=80) (n=153) (n=83) 
 (%) (%) (%) 
    
Biliary 51 60 51 
    
Benign 27 18 45 
    
Malignant 24 02 06 
    
Cryptogenic 20 15 45 
    
Portal vein 13 07 01 
    
Direct extension 10 03 0 
    
Trauma 5 5 0 
    
Hepatic artery 1 10 2 
    
 
 
Factors associated with liver abscess after biliary tract surgery 
 
  Anastomotic stricture (benign or malignant). 
 
  Foreign body (biliary stent, silk suture, sump syndrome). 
 
  Intrahepatic bile duct stricture. 
 
  Excluded bile duct segment (with external fistula). 
 
  Common duct stones. 
 
  Intrahepatic stones. 
 
  Vascular injury (hepatic arterial or portal venous). 
 
  Altered gastrointestinal flora (achlorhydria, duodenal diverticulum). 
 
 
 
 
22 
 
 
 
  
   Bacterial seeding via the hepatic artery is a further recognized cause of liver 
abscess. This may occur in subacute bacterial endocarditis or in other conditions 
associated with systemic bacteremia such as pneumonia, osteomyelitis, urinary 
sepsis or following intravenous drug abuse. 
   Hepatic artery catheterization may also be complicated by the formation of  
liver abscess. 
 
 Bacterial seeding may occur in the context of deficiencies of the host defenses. 
Branum et al (1990)13 have noted that there is an increase in the number of 
patients with underlying solid tumors or hematological disease. 
 
    Children with chronic granulomatous disease or other disorders of 
granulocyte function may also present with liver  abscess, most commonly due to 
organisms such as Staphylococcus aureus. Other authors have reported liver 
abscess in patients with the acquired immune deficiency syndrome.26 
 
    Liver abscess may also result from the direct extension of infection 
into the liver. This may occur with infection involving the subphrenic or pleural 
space,gallbladder, or when gastric or intestinal perforation occurs directly into the 
liver. 
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  TABLE – 5 : PATHOGENESIS OF PYOGENIC LIVER ABSCESS BY 
ETIOLOGY 
Etiology Source of infection Distribution Primary   
     microorganisms 
     
Biliary system Cholangitis,biliary Both lobes, Single species, gram (-) 
 obstruction  multiple  aerobes and anaerobes
     Ecoli    
      
Portal circulation Intra-abdominalinfection Right lobe > left Polymicrobial, enteric
   multiple or single aerobes and anaerobes
     Efaecalis, Ecoli,   B
     fragilis    
        
 Liver metastasis  Area of B fragilis   
   metastasis      
        
Arterial Bacteremia, systemic Both lobes, Single species, gram
circulation infection  multiple  (+)aerobes S aureus,
     Spyogenes   
      
Trauma Direct exposure,necrosis Area of injury Single species gram
     (+)aerobes S aureus,
     Spyogenes   
     
Direct extension Cholecystitis, perforated Adjacent area Single species, gram (- 
 ulcer    )aerobes E coli  
       
Cryptogenic Unknown  Right lobe > left Single  species,
     anaerobic B fragilis 
          
 
 
  Pathology 
 
    The etiology of a Hepatic abscess serves as the best predictor of the 
number, location and size  of abscesses affecting a given patient. 
 
    Generally, portal, cryptogenic and traumatic hepatic abscesses are 
solitary and large, while biliary and arterial abscesses are multiple and small. 
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    Overall, pyogenic liver abscesses highly localize to the right hepatic lobe in 
65% of cases, with the majority of these being solitary. The left lobe is rarely  involved 
in 12% of cases, with 23% of patients having bilateral abscesses. 
 
  The number of  multiple and bilateral abscesses has increased as more patients present 
with a biliary etiology. Bilateral disease occurs in 90% of the cases with a biliary or 
arterial source of infection, distributing along the terminal branches of the portal triad. 
    In contrast, hepatic abscesses resulting from the intra-abdominal infectious 
sources have a more propensity to develop in the right hepatic lobe, a process that may 
be explained by the preferential blood flow from the superior mesenteric vein to right 
lobe. 
 
  Fungal hepatic abscesses are most often multiple, bilateral, and miliary in nature. 
 
 
  Microbiology 
 
   The pyogenic nature of PLA is usually confirmed by microbiological 
culture. 
 
   This involves aspiration of the liver abscess together with blood 
culture. Abscess cultures are more likely to be positive than the blood cultures. 
Positive abscess cultures are found around 80 to 97% of thecases, whereas 
blood cultures are positive in around  50 to 60% of the cases.9,14,27. 
 
   In western countries, Escherichia coli is the most frequent organism isolated, 
in oriental series, Klebsiella pneumoniae may be the predominant 
organism.28,29 
   Other aerobic Gram-negative bacteria are frequently isolated including 
 
Proteus spp, Enterococci, Enterobacter spp Pseudomonas aeruginosa and 
Citrobacter spp.Bacteroides fragilis is the most common anaerobe,though 
other Bacteroides, anaerobic streptococci andClostridia spp  may also be 
found. 
25 
 
 
 
  
 
  TABLE – 6 : MICROBIOLOGICAL FINDINGS OF ABSCESS AND BLOOD 
CULTURES 
Organism Seeto and Seeto and Stain et al 1991  
 Rockey 1996 Rockey 1996  
  Stain et al 1991   
      
Organism Abscess (%) Blood (%)  Abscess (%) Blood 
     (%) 
      
Escherichia 35 15  14 07 
      
Klebsiella 28 13  12 10 
pneumoniae sp      
      
Enterococci 15 10  3 - 
      
Pseudomaonas sp 12 4  1 1 
      
Citrobacter sp 7 1  2 2 
      
Proteus sp - -  2 1 
      
Enterobacter - -  1 - 
      
Serratia  -  - 1 
      
Diphtheroids    7 8 
      
Streptococci -    - 
      
Alpha / Viridans 14 7  6 2 
      
Beta - -  6 2 
      
Delta - -  3 1 
      
Staphylococci 12 9  2 1 
      
Other GNRs 10 3  - - 
      
Other aerobes 6 2  - - 
      
Bacteroides sp 18 6  7 8 
      
Fusobacterium 7 3  1 2 
      
Peptostreptococcus 7 2  - - 
      
Lactobacillus 1 1  - - 
      
Other anaerobes 4 6  - - 
      
Microaerophilic - -  - - 
      
Streptococci 7 8  7 3 
      
Candida - -  2 - 
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  TABLE - 7 : ORGANISMS ISOLATED FROM PYOGENIC LIVER 
ABSCESSES 
Category of organism % of Patients 
  
 - 
GRAM-NEGATIVE AEROBES  
  
Escherichia coli 50-70 
  
Klebsiella pneumoniae 18 
  
Proteus 10 
  
Enterobacter 15 
  
Serratia Rare 
  
Morganella Rare 
  
Actinobacter Rare 
  
 - 
GRAM-POSITIVE AEROBES  
  
Streptococcal species 30 
  
Enterococcus faecalis 20 
  
B-Streptococci 10 
  
A-Streptococci - 
  
Staphylococcal species 15 
  
 40-50 
ANAEROBES  
  
Bacteroides species 24 
  
Bacteroides fragilis 10 
  
Fusobacterium 10 
  
Peptostreptococcus 5 
  
Clostridium 5 
  
Antinomyces Rare 
  
 26 
FUNGAL  
  
 7 
STERILE  
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    Microaerophilic streptococci have been shown to be the important 
components of liver abscesses. In one series, these organisms were identified in 
81% and 86% of positive  abscess and blood cultures respectively.30 
 
    Other Gram positive organisms such as  Group A streptococci and 
Staphylococcus aureus account for the remainder of isolates. Causative organisms 
tend to vary according to the underlying aetiology of  liver abscess. 
    Abscesses secondary to pyelophlebitis and cholangitis are frequently 
polymicrobial and usually involve Gram-negative organisms and anaerobic 
bacteria. 
 
    Systemic bacteremia commonly causes infection with a single 
organism, often Staphylococcus aureus, streptococci or other aerobic Gram-
negative organisms. 
 
    These organisms are more likely to cause liver abscess following 
trauma. Staphylococcus aureus is the predominant organism isolated from hepatic 
abscessesin children. 
 
    Hepatic abscess in childhood usually occurs as a result of chronic 
granulomatous disease,  haematological malignancy, or immunosuppression. 
 
  The main reasons for negative cultures probably related to poor anaerobic culture 
technique or the use of broad-spectrum antibiotics prior to abscess drainage. 
 
    Rubin et al (1974)31 analyzed culture techniques in 50 patients with 
pyogenic liver abscess. If culture techniques were adequate, 55% of samples grew 
anaerobic bacteria. 
 
    However, if culture techniques were considered inadequate, only 8% 
of samples yielded anaerobes. In the series reported by Sabbaj et al (1972).32 45% 
of cultures obtained from hepatic abscesses were found to be anaerobic. 
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    In this study, specimens were immediately placed under anaerobic 
conditions and promptly cultured using a variety of selective media. Aerobic 
organisms. 
 Were most commonly recovered as pure isolates whereas in case of anaerobic 
organisms which are more likely to be cultured in combination with aerobes. This 
would also suggest that many abscess contain anaerobes that are not isolated by 
routine culture techniques. 
 
    Recently pyogenic liver abscess secondary to Klebsiella pneumoniae 
has emerged as a distinct clinical entity in diabetic patients in a study.33 
 
    This would appear to be the  only one factor though, as 25% of patients 
with K.pneumoniae liver abscess do not have diabetes. 
    An increase in the number of patients with haematological malignance 
has contributed to the emergence of fungal abscesses.34 
 
    Patients with fungal abscesses have almost always undergone 
cytotoxic chemotherapy. 
 
    Hepatic abscess may be used by mycobacteria, though it is extremely 
rare. However, of the few patients with acquired immunodeficiency syndrome 
presenting with liver  abscess, mycobacterium tuberculosis is a common infecting 
organism.26 
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AMOEBIC LIVER ABSCESS 
CLINICAL PRESENTATION & LABORATORY INVESTIGATIONS 
 
   The symptoms and signs  of amoebic liver abscess vary according to  the 
location of the abscess and the gravity of the illness. 
 
   Less than 30% of patients have active diarrhoea during any time before 
presentation, even though intestinal infection by E. histolytica must have occurred. 
 
  A concomitant liver abscess is found in one  third of patients with amoebic colitis. 
Amoebic liver abscess occurs ten times more common in males. 
 
   While the peak incidence is between 20 and 60 years worldwide, it is 
predominantly a disease of young adult males. Children, especially neonates, 
pregnant women and women in the postpartum period have very much increased 
risk of severe disease and death. Treatment with steroids, malnutrition and , 
malignancy are other risk factors for severe disease.35 
 
    Typically, the onset is abrupt, with pain located in the right 
hypochondrium being the chief complaint. The pain may radiate to the right 
shoulder and scapular areas, and increase with the movements of coughing, deep 
breathing and walking. 
 
    If the abscess is located in the left lobe, the pain may be epigastric, 
precordial or retrosternal and may radiate to the left shoulder. An abscess located 
in the inferior aspect of the liver may present like signs of  peritonitis due to any 
upper abdominal cause. 
    The second most common feature is fever between 38 and 40oC, this is 
seen virtually in all patients. Other less common symptoms include anorexia, 
nausea, vomiting and an acute colitic illness. Occasionally the presentation is 
insidious, last for 2 or more weeks  and in such patients there will be significant 
weight loss may occur. 
 
    Physical examination reveals a tender, generalized and soft 
hepatomegaly which is usually accompanied by overlying muscle guarding, 
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intercostals tenderness and occasionally, increased warmth and subcutaneous 
edema. 
 
  Mild jaundice is often seen, though only in 5-8% of cases is it a prominent feature. 
 
   In its commonest location – the right posterior superior surface – amoebic liver 
abscess is mostly  accompanied by right basal lung signs. 
 
  A pericardial rub may occur in association with left-side abscess. 
 
  Signs of hepatic failure, splenomegaly and , ascites are rare. 
 
   Clinically, the usual differential diagnoses include  pyogenic liver abscess, 
acute cholecystitis and  hepatitis due to viral or other cause,. 
 
   With atypical presenation, liver hydatid or simple cysts hepatocellular 
carcinoma, may be considered. 
 
   Haematological investigations in amoebic liver abscess usually reveal 
leucocytosis (12000-30000 cells/ mm3) without eosinophilia. 
 
   Mild anemia may occur in one half of patients, although in young male 
alcoholics, hemoglobin may be normal or raised. 
 
   Liver function tests show moderate raise of alkaline phosphatase, direct 
bilirubin and transaminase levels. 
 
    The most common abnormality is an increased prothrombin time. 
 
  Chest radiography typically shows elevation of the right dome of the diaphragm 
with an anterior bulge on the lateral view, atelectasis of the right lung and pleural 
effusion. 
 
    The liver  shadow on plain abdominal film is diffusely enlarged, and is 
usually featureless. 
 
    Gas in the biliary tree or liver parenchyma indicates a pyogenic process 
unless there is communication of the hepatic abscess cavity with the lung or 
hollow viscus.36 
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       TABLE 8: CLINICAL PRESENTATION & LABORATORY 
 
INVESTIGATIONS 
 
 
SYMPTOM % of Amoebic Abscesses 
  
Pain 90 
  
Fever 87 
  
Nausea and vomiting 85 
  
Anorexia 50 
  
Weight loss 45 
  
Malaise 25 
  
Diarrhea 25 
  
Cough or pleurisy 25 
  
Pruritus <1 
  
SIGN  
  
Hepatomegaly 85 
  
Right upper quadrant tenderness 84 
  
Pleural effusion or rub 40 
  
Right upper quadrant mass 12 
  
Ascites 10 
  
Jaundice 5 
  
LABORATORY DATA  
  
Increased alkaline phosphatise 80 
  
WBC count >10,000/mm3 70 
Hematocrit <36% 49 
  
Albumin <3 g/dL 44 
  
Bilirubin >2 mg/Dl 10 
  
32 
 
 
 
  
DIAGNOSTIC INVESTIGATIONS: 
 
Ultrasonography 
 
   Though simple, inexpensive and quick to perform, with a diagnostic accuracy 
of 90%,35 interpretation of ultrasonographic findings against the clinical background 
and confirmation by serological tests is required to avoid major errors in diagnosis. 
 
   Abscesses are usually located peripherally in contact with the liver capsule and 
vary from 2 to 21 cm in size (mean 7.75cm). The outline is round, oval or lobulated. 
 
   The abscess, though clearly defined from the surrounding normal liver 
parenchyma with distal sonic enhancement, rarely has rim echoes that can be 
interpreted as an abscess wall. 
 
   The contents of the abscess cavity are usually hypoechoic and non-
homogenous, with the internal echoes increasing at high gain and decreasing or 
almost absent at normal gain. 
 
   In 78-80% of cases the abscess occurs singly and in the right lobe, 10% are in 
the left lobe, and the rest multiple. In up to 6% of cases the abscess may be located in 
the caudate lobe. 
 
   The mean resolution time is 7 months, and in 70% of patients the 
ultrasonographic findings persist for 6 months or more. 
 
   This must be taken into account when evaluating treatment responses, for 
which, serial scanning is unwarranted in patients with clinical improvement. 
 
   While pyogenic liver abscesses tend to resolve earlier, with 50% resolving in 2 
months and 90% within 4 months. 
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   Amoebic liver abscess acquire a more echogenic and fibrous wall in 8-16 
weeks and begin to resemble but should be differentiated from an encapsulated tumor. 
 
   With time, resolution may be complete or result in a small residual cystic 
cavity that resembles a simple cyst of the liver.37 
 
 
  TABLE 9 : ULTRASOUND CHARACTERSTICS OF LIVER ABSCESSESS72 
 
FINDINGS DURATION OF CLINICAL NUMBER OF 
 ILLNESS (WEEKS) ABSCESSES 
    
Wall    
Echo poor wall 1 - 3 32 
   
Fine echogenic rim 4-6 28 
Thick echogenic wall 8 - 12 4 
Contents    
    
Mixed hyper- and 1 - 3 22 
hypoechoic pattern    
    
Homogenous hypoechoic 4 - 8 30 
pattern    
    
Mixed hypo- and anechoic 8 - 16 12 
pattern    
    
Echogenic nodules 4 – 12 15 
    
 
 
  TABLE 10 : EVOLUTION AND HEALING OF AMOEBIC LIVER ABSCESS72 
 
ULTRASOUND DURATION OF ABSCESS 
CHARACTERISTICS  
  
Echo-poor wall with heterogenous echo 2 to 3 weeks 
pattern  
  
Fine echogenic rim with homogenous 4 to 8 weeks 
hypoechoic pattern  
  
Echogenic nodules 4 to 2 weeks 
  
Thich ecogenic wall with anechoic areas 8 to 16 weeks 
  
Complete healing 3 to 6 months 
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o Computed tomography 
 
   Especially in the acute situation, a computed tomography (CT) scan 
does not add to the diagnostic accuracy of ultrasound except in the evaluation 
of imminent rupture of abscess. 
 
   In the atypical or chronic case it may be of value-showing better rim 
enhancement with contrast in pyogenic liver abscess, and high CT density of 
the contents in necrotic liver tumors. 
 
 
o Magnetic resonance imaging 
 
   While current evidence is that magnetic resonance imaging is not 
significantly superior to CT in diagnosis of amoebic liver abscess, it may be 
useful in follow up of a treated cases, and in differentiating it from a hepatic 
neoplasm. 
 
   Untreated amoebic liver abscess, show up as heterogeneous abscess 
cavities that appear hypointense on T1- weighted and hyper-intense on T2-
weighted images. 
 
  Incomplete hyperintense rings can be seen at the abscess margin. 
 
   Reparative tissue changes are seen as early as 4 days after treatment 
and indicate a favourable response. Evidence of haemorrhage would show up 
on MRI, but the iron deposition is not typically in the periphery as in the case 
of a hematoma. 
 
o Angiography 
 
   Rarely required in the diagnosis of a straightforward amoebic liver 
abscess, angiography may be necessary in a case where carcinoma is difficult 
to exclude. 
 
 
35 
 
 
 
  
   Typically, and in contrast to a neoplasm, it reveals a hypovascular or 
avascular mass displacing the hepatic artery branches. 
 
   The venous phase images may likewise show displacement of the 
portal vein branches, but may on occasion show a block of the portal vein. 
 
 
o Gallium Scanning 
 
   Gallium scanning helps in the differentiation of amoebic from 
pyogenic abscess. Amoebic abscesses, lacking in neutrophils, appear as cold 
spots while pyogenic lesions are seen as warm spots. 
 
   However, owing to the long time taken in performing the scan and the 
relative safety and speed of diagnostic aspiration, the role of gallium scan is 
limited. It may be particularly useful in the differentiation between amoebic 
and pyogenic abscess. 
 
 
o Amoebic serology38 : 
 
   Patients with amoebic liver abscess virtually always (90-95%) have 
serum antiamoebic antibodies. 
 
   They can be demonstrated using either indirect hemagglutination 
(IHA) or counterimmunoelectrophoresis (CIE), which are similar in 
sensitivity. 
 
   The enzyme-linked immunosorbent assay (ELISA) technique is also 
highly sensitive and widely available. 
 
   Recent developments of this method have results in rapid and accurate 
diagnosis – the test being completed in 35 minutes. 
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   Antibody response is directly related to the duration of illness. It may 
be negative during the first week after onset. Titres reach a peak by the second 
and third months, decreasing to lower, but still detectable levels by 9 months. 
 
  Problems with interpreting serology results occur in endemic areas where 
widespread amoebic colonic infection can result in high titres without invasive 
colonic or hepatic amoebiasis. Its chief value lies in differentiating amoebic 
from pyogenic liver abscess and from hepatocellular carcinoma. 
   ELISA or haemagglutination assay cannot differentiate acute from 
remote infection in endemic areas. CIE and gel diffusion methods are less 
sensitive but may be more helpful in the diagnosis of current infection in 
endemic areas, as the results become negative 6 to 12 months after acute 
infection. Efforts are on to identify antigens specific for acute infection.17 
 
 
TEST PRINCIPLE38: (ELISA IgG Antibodies detection)  
 
  Purified antigens are coated to a microwell plate. Antibodies in the 
patient samples bind to the antigens and are determined during the second step by 
using enzyme-labelled Protein A (the conjugate). The enzyme converts the 
colourless substrate (urea peroxide/TMB) to a blue end product. The enzyme 
reaction is stopped by adding sulphuric acid and the colour of the mixture 
switches from blue to yellow at the same time. The final measurement is carried 
out at 450 nm on a photometer using a reference wavelength ≥ 620 nm. 
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Specimen collection and storage 
 
 The test has been developed for testing human serum samples. After blood collection, 
the blood should be separated from blood clots as soon as possible in order to prevent 
haemolysis. The serum which was separated aseptically was stored at 2-8oC until they are 
tested. Haemolytic, icteric or turbid samples were not used, as it can lead to false results. 
 
 
Test Procedure: 
 
 
1. Bring the microwell plate PLATE and reagents to room temperature (20 – 25 o C) 
 
 
2. Dilute the wash buffer WASH with distilled water 1:20. 
 
 
3. Dilute the serum samples with the sample buffer DILUENT 1:50. 
 
 
4. Place enough wells for positive control , negative control (in double determination), 
and samples in the frame plate. 
 
5. Pipette 100 microl positive control CONTROL + , negative control CONTROL – or 
sample into the wells. 
 
6. Incubate at room temperature (20 -25 o C) for 15 minutes. 
 
 
7. Empty the microwell plate and then wash it 5 times with 300 microl diluted wash 
buffer. 
 
8. Place 50 microl (or 1 drop) substrate SUBSTRATE and chromogen CHROMOGEN 
in each of the wells. 
 
9. Incubate at room temperature (20 – 25 o C) for 15 minutes. 
 
 
10. Add 50 microl (or 1 drop) stop reagent STOP. 
 
 
11. Carry out a photometric measurement at 450 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 : Amoebic
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 Serology (ELISA) Test Procedure 
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Evaluation and interpretation 
 
Calculating the sample index 
 
1. The average absorbance is calculated for the negative control. 
 
2. 0.150 is added to the average absorbance. This yields the cut-off for the test. 
 
3. The sample index is obtained by dividing the absorbance for the sample by the 
cut-off. 
For example:    
Negative control 1 O.D. = 0.115 
Negative control 2 O.D. = 0.125 
Sample O.D. = 0.508 
cut-off = 0.115 + 0.1252  + 0.150 = 0.270 
  2   
Sample index =  0.5080.270 =  1.88 
 
 
 
  TABLE 11: EVALUATING THE SAMPLE INDEX 
 
 Negative Equivocal Positive 
    
Sample Index < 0.9 0.9 -1.1 > 1.1 
    
 
 
Limitations of the method 
 
® 
RIDASCREEN E. histolytica IgG EIA detects IgG antibodies against 
Entamoeba histolytica. and should be carried out in cases of suspected Amoebiasis. 
The results obtained must always be interpreted in combination with the clinical 
picture and other diagnostic findings. 
 
Antibody signals are dependent on the localization of the parasitosis and may 
vary from patient to patient. 
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If the amoebae findings in the stools are positive, a positive antibody 
determination will mean that E. histolytica can be identified in the strict sense as the 
cause of the clinical symptoms. 
In cases of suspected extraintestinal dispersal of the parasite, a positive 
antibody determination can indicate amoebiasis, even if the stool findings are 
negative; the findings should be con-firmed by clinical symptoms and other diagnostic 
methods. 
 
RIDASCREEN® E. histolytica IgG 04-07-23 
 
 
A negative result does not necessarily rule out the possibility of amoebiasis. 
During the early stages of the infection, the number of antibodies may be so small that 
the test yields a negative or equivocal result. In cases of suspected amoebiasis based 
on the case history, another serum sample should be tested after a few days. A 
positive result does not rule out the presence of another infectious pathogen 
 
 
  TABLE 12: SENSITIVITY AND SPECIFICITY IN COMPARISON 
WITH TWO OTHER COMMERCIAL ELISAS 
 
 
IgG  
 
Sensitivity 100.0%  
 
Specificity 95.6%  
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PYOGENIC LIVER ABSCESS  
 
DIAGNOSIS 
 
Clinical features & Laboratory Investigations. 
 
  The clinical presentation of PLA is often sub-acute. 
 
  Symptoms may have been present for many weeks prior to hospital admission. 
 
  In addition, diagnosis is often delayed for several days following 
hospital admission. 
 
  Fever is the most frequent and consistent presenting symptom. 
 
   Abdominal pain is also a frequent complaint, though this is not 
necessarily localized to the right upper quadrant. Many patients also complain 
of a variety of non-specific symptoms such as malaise, anorexia, nausea, 
vomiting and weight loss. 
   Diaphragmatic involvement may also result in pleuritic type pain and 
symptoms of cough and dyspnoea are not infrequent. Occasionally patients are 
admitted with sepsis syndrome or with peritonitis secondary to intraperitoneal 
rupture of hepatic abscess. Rarely a hepatic abscess may rupture into the right 
pleural space or pericardium. 
 
   Other than fever, right upper quadrant tenderness and or hepatomegaly 
are the most common physical findings. 
 
   Seeto & Rockey (1996)9 found that 60% of patients had one or both 
these physical signs. However, only approximately one-third of patients were 
found to have the classic findings of fever and right upper quadrant 
tenderness. 
 
   Jaundice was present in approximately 20% of patients and this was 
suggestive to underlying biliary tract disease. 
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   Chest signs, specifically related to the right lung base were present in 
25% of patients in this series. 
   Almost all patients with pyogenic liver abscess have abnormal 
haematological and liver function tests. Leukocytosis is noted in 
approximately 70 to 90% of patients. 
  Many patients are also found to be anaemic and this usually reflects the 
presence of chronic disease or a prolonged sub-acute presentation. 
  Erythrocyte sedimentation rate (ESR) is almost always elevated. 
   The most frequent liver function test abnormality observed in patients 
with hepatic abscess is an elevated alkaline phosphatase. This is seen in 
approximately 80% of patients. 
   Bilirubin is elevated in 20 to 50% of patients. Transaminases are also 
abnormal in up to 60% of patients. Hypoalbuminemia is observed in 
approximately 70% of patients and mild elevations of prothrombin time are 
also frequently seen. 
43 
 
 
 
  
 TABLE – 13 : SYMPTOMS AND SIGNS OF PYOGENIC LIVER ABSCESS9 
 
Symptoms No. of patients Percentage 
   
Fever 95 79 
   
Chills 73 60 
   
Abdominal pain 67 55 
   
Nausea 45 37 
   
Vomiting 36 30 
   
Weight loss 34 28 
   
Pleuritic chest pain 25 21 
   
Cough or dyspnea 25 21 
   
Diarrhea 24 20 
   
Abdominal distention 6 5   
Signs   - - 
    
Admitting temperature  - - 
     
> 38.5   54 39 
     
37.5 – 38.4   34 24 
   
Tender right upper quadrant 61 43 
    
Hepatomegally  39 28 
    
Abnormal chest findings  39 28 
     
Jaundice   29 28 
     
Guarding, rebound or 24 17 
Murphy’s sign    
    
Tender epigastrium  21 15 
    
Abdominal distention  18 13 
     
Ascites   6 4  
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Diagnostic imaging  
 
    Plain abdominal and chest radiographs are now used less frequently in 
the assessment of patients with hepatic abscess, though they may still be of 
diagnostic value. Chest radiographs are abnormal in approximately 50% of patients 
presenting with hepatic abscesses. Changes suggestive of sub-diaphragmatic 
pathology include an elevated right hemidiaphragm, a right pleural effusion and 
right lower lobe atelectasis.  
   Similar findings are occasionally found in the left thoracic cavity, if the 
abscess involves the left hepatic lobe. Abdominal films may show evidence of 
hepatomegaly. If gas-forming organisms are present within the abscess, an air fluid 
level may be seen. Air within an unoperated biliary tree may also be demonstrated, 
confirming the diagnosis of cholangitis. Rarely portal venous gas may be seen on an 
abdominal X-ray, confirming pyelophlebitis. Portal venous gas appears as branching 
linear lucencies along the peripheral portion of the liver. Air within the biliary tree 
tends to be seen more centrally. However, it is rarely possible to make this 
distinction on the basis of plain film appearances alone and US or CT are usually 
required. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4. : CXR showing an air fluid level within a large right lobe abscess. Elevation of 
right hemi diaphragm and a loculated pleural effusion are also noted 
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  TABLE 14 : DIAGNOSTIC RADIOLOGIC TECHNIQUES FOR 
DIAGNOSIS OF PYOGENIC LIVER ABSCESS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ULTRASONOGRAPHY AND CT SCANNING  
 
   Abdominal US and CT both have major roles to play in the diagnosis 
and management of patients with pyogenic liver abscess. Ultrasonography 
shows pyogenic abscesses to be round or oval areas that are usually less 
echogenic than the surrounding liver. Computed tomography shows hepatic 
abscesses to be of lower attenuation than the surrounding liver.  
   The administration of intravenous contrast also results in intense 
enhancement of the abscess wall. Ultrasound is particularly useful in 
distinguishing solid from cystic lesions; it is cost effective, readily available 
and has the advantage of being portable. However, ultrasound has a number of 
limitations. 
 
  Ultrasound has a sensitivity of 80 to 95% for the detection of hepatic abscess. 
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   Computed tomography may visualize hepatic collections as small as 
0.5 cm and CT may more easily identify multiple small abscesses. Computed 
tomography has been shown to be slightly more sensitive than US, with a 
sensitivity of 95 to 100%.39,13,27,29,24,9. Both CT and US have the added 
advantage of being able to detect other biliary and abdominal pathology. 
Computed tomography is particularly sensitive for the detection of abdominal 
mass lesions such as complicated appendicitis or diverticulitis. Seeto and 
Rockey (1996)9 found that, for non cryptogenic hepatic abscess, CT scan was 
able to identify the underlying cause in 69% of patients. 
 
   However, in addition to establishing the diagnosis, the main advantage 
of these imaging modalities is that they facilitate definitive treatment by way 
of US or CT guided aspiration or drainage. 
 
   Radionuclide scanning with 99mTc was the first form of imaging that 
reliably detected mass lesions within the liver. This technique has a sensitivity 
of approximately 80% for the detection of liver abscess.39 However, its role in 
the detection of hepatic abscess has now been completely replaced by US and 
CT. 
 
   Angiography is now also rarely used in the diagnosis of hepatic 
abscess. 
 
  Magnetic resonance has recently been used for the detection of hepatic 
abscess. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
 
 
  
MANAGEMENT STRATEGIES:  
 
  AMOEBIC LIVER ABSCESS 
 
The management of amoebic liver abscess varies from conservative (medical) 
management, needle aspiration, pigtail catheter drainage to open drainage depending 
on various criteria. Amoebic liver abscess, undiagnosed and untreated, had a very 
high mortalty rate, of almost 100%. With early diagnosis and prompt institution of 
specific therapy, the prognosis is excellent and the mortality is extremely low. The 
treatment and diagnosis of amoebic liver abscess has been changed dramatically over 
the last three decades due to the availability of newer improved amoebicidal agents, 
newer imaging modalities and guided percutaneous aspiration and catheter drainage 
techniques and improved anaesthetic, surgical, and postoperative management in 
cases of ruptured amoebic liver abscess. 
 
Before 1900, the treatment of amoebic liver abscess was primarily of free 
incision and drainage. But that procedure was associated with high morbidity and 
mortality rate was reported to be at least 60%. Thus the treatment of amoebic liver 
abscess shifted to more towards the closed aspiration with the view , to avoid 
secondarily bacterial contamination of abscess cavity. The open drainage of abscess 
was done only in large amoebic liver abscess and of long duration. Closed aspiration 
was indicated in amoebic liver abscess as late studies suggested that living amoebae 
was found in the walls of undrained tropical abscess, two thirds of the tropical 
abscesses were free from bacteria when opened, and that amoebae of liver abscesses 
were rapidly killed by weak solutions of quinine. The open drainage used to be done 
in cases of suspected amoebic live abscess, if on microscopic examination of pus 
(aspirated from abscess) shows bacteria, otherwise repeated aspiration and injection 
used to be the treatment of amoebic liver abscess. 
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The rule, then, is to aspirate all liver abscess cases unless the pus is pointing at 
the surface, and many cases are cured in this way without exposure to the risks of 
incision. If incision subsequently becomes necessary, the previous aspiration of the 
abscess is not found to prejudice the patient's chance ofrecovery.40 
 
 As early as 1935, Ochsner and De-Bakey advocated the following three principles of 
treatment41.  
 
  Every case of suspected amoebic liver abscess should be given a course of 
amoebicidal drug therapy before any other procedure is used, unless rupture of 
the abscess appears imminent. 
 
  If evacuation of pus is necessary, aspiration and preliminary administration of 
amoebicidal drugs is the procedure of choice. 
 
  Open drainage of the abscess should be reserved for the relatively few cases of 
secondarily infected abscesses. 
 
 
Thus, the management of uncomplicated amoebic liver abscess includes 
conservative, needle aspiration, pigtail catheter drainage and open drainage depending 
on the patients clinical features. Since ages the amoebic liver abscess has been known, 
the treatment of amoebic liver abscess has been a matter of debate. With major 
consensus, the mainstay of treatment has been medical since ages while closed 
drainage versus open drainage has been a matter of hot debate till now. 
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Earlier surgical drainage was indicated in the following conditions:  
 
 
  Patients not responding to medical treatment in spite of repeated needle aspiration 
or antiamoebic therapy. 
 
  Presence of more than one abscess cavity. 
 
  Doubt in diagnosis, or of the presence of a coexisting carcinoma or cirrhosis. 
 
  Lesions pointing below the costal margin, for fear of complications that may 
result from needling of neighboring viscera, and abscesses of the left lobe liver 
presenting as epigastric masses. 
 
  Patients presenting with complications such as peritonitis, empyema thoracis, 
abscess bulging through the abdominal wall, pericarditis, hemobilia, obstructive 
jaundice, and metastatic abscess. 
 
  Thrombosis of portal vein or inferior vena cava or fistulous connection with 
hepatic ducts; and 
 
  Recurrent or refractory abscesses. 
 
 
 
 
 
Role of Aspiration  
 
   In the era before ultrasonography became widely available, aspiration 
of the typical ‘anchovy sauce’ pus from the liver was often considered vital to 
confirm the diagnosis of amoebic liver abscess. Nowadays, ultrasound-guided 
aspiration is often justified on the basis that the diagnosis will then be ‘more 
certain’ or that the abscess can be ‘aspirate to dryness’ at the time of 
diagnostic aspiration. The controversy about routine aspiration of 
uncomplicated amoebic liver abscess remains unresolved. 
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   Aspiration is therefore, now regarded as generally superfluous in the 
management of amoebic liver abscess, and should be reserved for situation when : 
 
♣ Amoebic serology is inconclusive, delayed, or unavailable and the main differential 
diagnosis is a pyogenic liver abscess. 
 
♣ A therapeutic trial with antiamoebic drugs is deemed inappropriate (as in 
pregnancy). 
 
♣ There is suspicion of secondary infection of the liver abscess. This is estimated to 
occur in 15% of cases. 
 
♣ When fever and pain persist for more than 3 to 5 days after starting appropriate 
therapy, aspiration may provide symptomatic relief. 
 
♣ In extremely large abscesses (>5cms and volume >200cc) where rupture is 
suspected to be imminent, especially when pericardial rupture from a left lobe 
abscess appears likely. 
 
♣ Single aspiration may be sufficient for diagnostic purposes, but when performed as 
part of therapy is likely to be inadequate. When more than one aspiration is 
required, the placement of a percutaneous drain is probably indicated to reduce the 
risk of recurrence.43 
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CHEMOTHERAPY:  
  TABLE 15 : MEDICAL TREATMENT OF AMOEBIC LIVER ABSCESS 
 
 ADULT   
DRUG DOSAGE ADVANTAGES SIDE EFFECTS
Metronidazole44 
750 mg tid x 7-10 Achieves high 
 
Half life is 8 hours. Headache (10%), days concentration in 
High 
 liver with small dizziness, nausea, 
And 30-35mg/kg amounts of drug, anorexia, Heavy coating 
concentrations in 
body wt. in three absorbs rapidly, of tongue, brownish 
liver, stomach, 
divided doses for rapidly excreted urine, metallic taste, 
kidney, intestine, 
10 days in without cumulative ataxia(<1%), seizures, 
crosses placental 
children effect. paraesthesias, peripheral 
and blood brain   
reaction with alcohol. 
barriers. 
  
   
Tinidazole 
2gm/day divided 
similar Similar 
tid x 3 days    
Emetine 
 More effective  
 
against trophozoites 
 
Hydrochloride 
1mg/kg/day (max. Regional Myositis, 45,46(Used where than cysts, mainly 
rapid clinical 60 mg/day) for no 
concentrated in 
CVS – hypotension, liver. Tissues level 
response is more than 10 
persists for 40-60 tachycardia, chest pain , 
required or days. 
days after dyspnoea, ecg changes. 
Metronidazole 
 
 
termination of 
 
response is poor) 
  
 
treatment 
 
   
Chloroquine 
1 gm (600 mg  
C/I in patients with base) per day for  
phosphate 46(used 2 days followed  retinopathy and in 
in recurrent or by 500 mg (300  psoriasis 
resistant cases) mg base) per day  Other side effects – G.I. 
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for 2-3 weeks 
 
  upset, headache, visual 
   disturbances and pruritis. 
  Effect in cyst  
  passers therefore 
Flatulence, nausea, 
Diloxanide furoate 500 mg tid x 10 
used for treatment 
of asymptomatic vomiting, pruritis, 
 days carriers, family urticaria 
  members and  
  intimate contacts of  
  patients diagnosed  
  liver abscess  
Parmomycin 25-35 mg/kg/day  G.I. upset (1-10%), 
 divided tid x 7  headache, vertigo, 
 days  eosinophilia, rash 
Iodoquinol 
650 mg tid x 10  Optic neuritis with long 
days 
 
term use.    
 
53 
 
 
 
  
Therapeutic strategy  
 
    Metronidazole is administered as a single drug after diagnosis, with 
concomitant correction of hypoprothrombinemia, hypoproteinemia and anemia. If 
dramatic improvement in 48-72 hours is noted, no other therapy other than the 
complete course of metronidazole is required. A luminal agent such as Diloxanide 
furoate (500 mg p,o, t.i .d. x 10 days) or Paromomycin (30 mg/kg/day in 3 doses x 
10 days) must be administered following metronidazole therapy for the eradication 
of intestinal infection as a part of the complete treatment. 
    In patients who do not respond satisfactorily, emetine or 
dehydroemetine is added. Evidence of pulmonary, peritoneal or pericardial 
extension is a indication for aspiration of the liver abscess with an intercostal tube 
or catheter drainage into a closed-circuit collection system. Failure to adequately 
control the abscess by these means – increasing signs or peritonitis, fistulization 
into a hollow viscus or secondary infection with septicaemia constitutes an 
indications for laparotomy.47 
 
 
PREVENTION  
 
  Modern biologic techniques have helped to characterize amoebic antigents which 
show great promise towards the development of a vaccine. These antigens include: 
o Serine rich Entamoeba histolytica protein (SREHP) 
o A 170 kD subunit of Gal / Gal Nae binding lectin and 
o A 29 kD cysteine rich protein  
   Recombinant vaccines based on these antigens have been successfully used in 
animal models of amoebiasis. Attempts an: now afoot to fuse these antigens with 
the relevant subunits of cholera toxin and salmonella species to develop an oral 
combination 'enteric pathogen' vaccine. 
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PYOGENIC LIVER ABSCESS:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Once a diagnosis of hepatic abscess is suspected, broad spectrum intravenous 
antibiotics should be started. The diagnosis of hepatic abscess should be confirmed by 
the aspiration of pus at the time of US or CT scan. Antibiotic therapy can be adjusted, 
once the results of abscess cultures are available. Blood should also be sent for 
culture. Specimens should be cultured for acid-fast bacilli and fungi and this is 
particularly the case if there is a clinical suspicion of mycobacterial or fungal 
infection or if patients are immunosuppressed. Empirical antibiotic therapy should 
include effective cover against aerobic Gram-negative bacteria, streptococci and 
anaerobic bacteria. Appropriate antibiotic combinations would include ampicillin, and 
aminoglycoside and metronidazole or a third generation cephalosporin such as 
cefotaxime together with ampicillin and metronidazole, alternatively a carbapenem 
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antibiotic such as imipenem or meropenem may be used. Metronidazole will also be 
therapeutic for patients with amoebic liver abscess. All patients, at risk of amoebic 
liver abscess should also undergo serological testing. The duration of antibiotic 
treatment will vary according to the clinical setting. However, antibiotic penetration 
into abscess cavities is often poor and 2 weeks of intravenous antibiotics are usually 
recommended. Appropriate oral antibiotics are then usually continued for a further 4 
weeks. 
   Extraperitoneal drainage was recommended so as to avoid contamination of 
the peritoneal cavity. This was usually achieved via a posterior approach through the 
bed of the twelfth rib. However, with the availability of modern antibiotics, 
transperitoneal drainage may now be performed safely and this approach has the 
advantage of allowing full laparotomy and assessment of any underlying 
intraabdominal pathology. For patients with a known source of infection within the 
abdomen or biliary system, definitive surgery may be performed, followed by abscess 
drainage. 
 
   However , Bertel et al (1986)48 published a series of 39 patients with pyogenic 
hepatic abscess: 23 patients were treated surgically, 16 patients underwent 
percutaneous drainage. Three of the percutaneously treated group required surgical 
drainage due to viscous abscess contents. However, the majority of patients were 
successfully treated. Mortality was 17% in the surgical group and 13% in the 
percutaneously drained group. 
 
   Wong (1990)49 described 21 patients with pyogenic liver abscess treated by 
percutaneous drainage. This was successful in 85% of patients with a mortality of less 
than 10%. Contraindications to catheter drainage include the presence
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of ascites, coagulopathy and proximity to vital structures. Unfortunately, there are no 
randomized controlled trials comparing surgical and percutaneous drainage and raw 
comparisons between these two groups will inevitably be subject to selection bias. 
However, many authors have since confirmed the safety and efficacy of percutaneous 
aspiration or drainage and this is now considered the treatment of choice for patients 
presenting with hepatic abscess.50 Surgery should now be reserved for patients with 
an identified intraabdominal source of sepsis in which a concomitant surgical 
procedure is planned or for patients who fail to respond to percutaneous treatment. 
 
   In 1996, Seeto and Rockey reported a series of 142 patients admitted between 
January 1979 and December 1994, Percutaneous drainage was successful in 90% of 
these patients. 
 
 
  TABLE –16 : THE TREATMENT OF PYOGENIC LIVER ABSCESS 
 
    Success   Mortality  Complications
             
   Surgery PNA PCD Surgery PNA PCD Surgery PNA PCD
    (%)   (%)   (%)  
             
Seeto  and 61 58 77 13 6 6 - - - 
Rockey 1979- (n=23) (n=17) (n=70)       
1994 (1996)          
             
Branum et al 81 - 83 9.5 - 25 48 - 71 
1970-   (n=28)  (n=18)       
1986(1990)          
             
Rintoul et al 100 - 60 0 - 33 0 - 40 
1989-   (n=1)  (n=15)       
1993(1996)          
             
Stain et al 66 79 83 0 2 0 0 7 4 
1984-   (n=3) (n=29) (n=23)       
1990(1991)          
            
Karatassas  69 60 - 43 - 0 - -  
1980-   (n=14) (n=18)        
1987(1990)          
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THE TREATMENT OF PYOGENIC LIVER ABSCESS  
 
There remains some controversy regarding the respective roles of 
percutaneous catheter drainage (PCD) and percutaneous needle aspiration (PNA) for 
the treatment of patients with liver abscess. It has recently been suggested that 
percutaneous aspiration may be preferable to catheter drainage. The main advantages 
of needle aspiration over catheter drainage are the fact that it is less invasive, less 
expensive and needle aspiration avoids the problems related to follow-up catheter care 
or loss of catheter position. 
However, incomplete evacuation of the abscess cavity or rapid reaccumulation 
of abscess contents following percutaneous aspiration were considered indications for 
continuous catheter drainage. Percutaneous needle aspiration appears to be less 
effective than PCD, though both procedures were shown to be safe with no major 
complications and no deaths.51 
 
.  Abscess communication with the intrahepatic biliary tree does not prevent 
abscess collections being successfully treated by percutaneous drainage. Studies have 
shown that, in the absence of biliary obstruction, abscesses with intrahepatic biliary 
communication are treated with equal efficacy by percutaneous drainage, though the 
period of abscess drainage may be prolonged.52 This is in contrast to patients with 
extrahepatic biliary communication when surgery and biliary diversion are usually 
required. 
 
Liver resection is occasionally required for patients with pyogenic liver 
abscess. The indication for this is usually hepatolithiasis or intrahepatic biliary 
stricture. In other patients, hepatic destruction may be so severe that they are best 
served by liver resection. Clearly risks are involved as manipulation may produce a 
life-threatening bacteremia. It is therefore recommended that, following ligation of the 
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vascular inflow, the involved hepatic vein should be ligated before parenchymal 
dissection is carried out. 
Laparoscopic drainage is an attractive alternative for patients requiring open 
surgical drainage.53 The advantages of laparoscopic surgery in terms of reduced 
analgesia requirements, reduced morbidity, faster postoperative recovery and shorter 
hospital stay compared to laparotomy are well documented. Laparoscopic localization 
of liver abscess may be more difficult than at open surgery due to lack of tactile 
feedback. However, aspiration with a long endoscopic or spinal needle may aid 
localization. Laparoscopic US is also likely to be useful in this respect. 
 
A number of following studies have attempted to identify factors that are 
predictive of poor outcome. 
 
  TABLE – 17 : PYOGENIC LIVER ABSCESS : FACTORS PREDICTIVE OF 
MORTALITY 
Lee et al Mishingeret al 
Chou et al(1994)
Chu et al Huang et al
 
(1991) (1994) (1996) (1996)(1973-1993)   
 
     
 
Clinicaljaundice Bilirubin >1.5g/dL Age > 60 Female gender Multipleabscesses 
 
     
 
Pleuraleffusion Leukocytosis>15.000/mm3 
Gas forming 
Rupture of abscess Malignancy 
 
abscess 
 
     
 
Bilobarabscess Haemoglobin<11 g/dL Rupture of abscess 
Emergency 
Jaundice  
laparotomy      
 
     
 
Albumin <2.5 
APACHE II Bilobar abscess Malignancy Hypoalbuminemia  
g/Dl      
 
     
 
Bilirubin >2 
Malignancy Clinical sepsis Hyperglycemia Leukocytosis  
mg/dL      
 
     
 
AST >100 IU/L  Bilirubin >2 mg/dL Hyperbilirubinemia Bactermia 
 
     
 
Alkaline  
Urea nitrogen >20 Elevated prothrombin 
 
 
phosphatase >150  Septic shock 
 
IU/L 
 mg/dL time  
 
    
 
     
 
Leukocytosis >20  Creatinine 
Elevated APTT 
 
 
000/mm3 
 
>2mg/dL 
 
 
   
 
     
 
  AST > 100 IU/L   
 
     
 
  Albumin <2.5 g/dL   
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OUTCOME  
 
 The last 60 years have seen a continued improvement in the prognosis of 
patients with pyogenic liver abscess. In the preantibiotic era, prior to the introduction 
of surgical drainage, pyogenic hepatic abscess was almost always fatal. With the 
introduction of surgical drainage and systemic antibiotics and widespread availability 
of Ultrasonography and CT scan facilitated earlier diagnosis and the development of 
percutaneous methods of drainage resulted in lower mortality. Following studies 
shows mortality rate . 
  TABLE 18 : MORTALITY RATE 
 
STUDIES MORTALITY 
  
Miedema % Dineen (1984) 50% 
  
John Hopkins series (1952-1972) 65% 
(1972-1993) 31% 
  
Branum et al  (1990) 19% 
  
Seeto & Rockey (1996) 11% 
  
 
 
The incidence of pyogenic liver abscess appears to be increasing. This is in 
part due to a more aggressive approach to the treatment of patients with hepatobiliary 
and pancreatic malignancy and the increasing use of cytotoxic drugs. Uncomplicated 
pyogenic liver abscess is now a disease with a good prognosis.  
This is illustrated by the fact that patients with cryptogenic liver abscess may 
have a mortality as low as 2%.9 Factors such as delayed presentation and delayed 
diagnosis may both contribute to poor outcome. However, the major factor now 
contributing to mortality in patients with pyogenic liver abscess is the severity of the 
underlying disease and in particular the presence of malignancy.  
It is the management of these patients that will continue to provide a clinical 
challenge in the future. 
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COMPLICATIONS OF LIVER ABSCESS54,55,46  
 
Communication or extension of liver abscesses occur into neighboring cavities 
and organs – the peritoneum, viscera and large vessels on one side of the diaphragm 
and the pleura, bronchi, lungs and pericardium on the other. 
 
 
TABLE 19 : COMPLICATIONS OF LIVER ABSCESS 
 
COMPLICATIO FEATURES   USG/CT MANAGEMENT  
NS       SCAN      
             
AMOEBIC             
LIVER             
ABSCESS             
1. Secondarily Most common, features -  Aspiration  and
 Infected of Peritonitis      Drainage    
 (10.0%)             
2. Peritoneal  or Incidence of spontaneous Shows  Laparotomy  and
 Visceral rupture – 2.7 – 17%of Perihepatic drainage   or
 involvement cases.      collection Laparoscopy drainage 
 (Ruptured) Presentation: Abdominal but difficult - Appearance as tan – 
 (18 – 70%) Pain,  Mass  or to say coloured bulge on the 
  Generalised Distension, whether it surface.    
  Tender Hepatomegaly, is a actual Mortality rate (12% - 
  Intercostal Tenderness, leak or 50%)    
  Right Basal Lung Signs, reactive      
  Clinical Jaundice and from      
  sudden bloody diarrhoea abscess      
  (Colonic Rupture) and cavity.      
  Haemetmesis         
  (Hepatogastric fistula)       
3. Thoracic or Presented as Sympathetic Pleural  Thoracentesis, rarely
 Pleuropulmonary straw  coloured right effusion  Pulmonary    
 involvement sided effusion, rupture   Decortication,   
  into pleural cavity,  Postural Drainage,
  bronchial  tree –   bronchodilators and
  Dyspnoea, dry cough,   anti-amoebic drugs – 
  Right basal crepitations,   Metronidazole. Or a
  pleural rub      combined approach.  
3. Pericardial Abscess of Left lobe Pericardial Pericardiocentesis +
 involvement more prone  for this thickening Liver abscesss
  complications.   or  Aspiration followed
  May  range  from Pericardial by Antiamoebic drugs 
  Pericardial effusion  to effusion      
  Pericardial Tamponade       
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MATERIALS AND METHODS 
 
This study was conducted in  RAJIV GANDHI GOVT GENERAL HOSPITAL, 
CHENNAI during the period of  March 2016- August 2017. 
 
INCLUSION CRITERIA 
 
                       Liver abscess in alcoholic and nonalcoholic patients, who are admitted in 
Institute of General Surgery, Rajiv Gandhi Government General Hospital, Chennai 
 
EXCLUSION CRITERIA 
 
  1) Age <18 years 
  2) Liver abscess in Malignancy. 
  3) Traumatic liver abscess 
 
MODE OF EVALUATION 
 
  Patient data  collected from all patients admitted in General Surgery 
department, Rajiv Gandhi Government General Hospital, Chennai.  Detailed history of 
patient will be entered in proforma. 
   Complete haemogram , LFT, Prothrombin time, urea, creatinine will be sent 
immediately on presentation. 
 
¾     Preliminary Ultrasound of Abdomen and Pelvis  done on the same day of 
 presentation. CECT done  if needed. 
¾     Treatment of patient done  based on patient condition according to hospital 
protocol. 
¾      Patient planned for surgery  informed consent  taken. 
 
STATISTICS 
 
Proportion (%) of various outcomes of  liver abscess studied and tabulated below. 
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TABLE NO:30 GGT 
 
GGT(>30IU/L) FREQUENCY PERCENT 
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NO 
 
TOTAL 
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DISCUSSION 
 
Abscess of the liver is relatively rare. It has been described since the time of 
Hippocrates (400 BC), with the first published review by Bright appearing in 1936. In 
1938, Ochsner's classic review heralded surgical drainage as the definitive therapy; 
however, despite the more aggressive approach to treatment, the mortality rate 
remained at 60-80%.1 
 
The development of new radiologic techniques, the improvement in 
microbiologic identification, and the advancement of drainage techniques, as well as 
improved supportive care, have decreased mortality rates to 5-30%; yet, the prevalence 
of liver abscess has remained relatively unchanged. Untreated, this infection remains 
uniformly fatal. 
 
The changing scenario in incidence, diagnostic methods, treatment 
&complications associated with liver abscess due to increasing percentage of 
alcoholics. the current serious problem in our country, has inspired me in doing an 
indepth study, regarding Liver Abscess, which assumes more importance in our country 
where rural population constitutes approximately 70% and therefore it mandates, 
appropriate & realistic guidelines to be drawn up for early diagnosis and change in 
management strategies, in order to reduce the morbidity and mortality associated with 
it. 
 The collected data were analysed with IBM.SPSS statistics software 23.0 
Version. To describe about the data descriptive statistics frequency analysis, 
percentage analysis were used for categorical variables and the mean & S.D were used 
for continuous variables.  
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AGE AND SEX INCIDENCE  
 
 Most of the patients who presented with Liver Abscess were in the middle age 
with patients in third to fifth decade accounting for 71.0% of the cases. Mean age of 
presentation is 42yrs, which is comparable to other Studies. 
Studies Mean Age[ in years] 
   
Shyam Mathur56 20 – 45 years (32.5 years) 
  
Khee Siang Chang, Chin Ming57 47.6 years 
    
Antonio Grorgia58 16 – 78 years ( 45.3 years) 
    
Present study 18 – 68 years (42 years) 
    
 
 
Studies Male Female 
   
Shyam Mathur56 90.0 % 10.0% 
   
Indian Journal Of Surgery200259 96% 04% 
   
Present study 90.0% 10.0% 
   
 
 
Present study shows a very high incidence of Liver Abscess in males [90.0%] as seen 
in other Indian studies like Shyam Mathur [90.0%] and Indian Journal Of Surgery [96.0%] 
 
SYMPTOMS & SIGNS  
 
Most of the patients who presented in this series presented with Fever 
[74.0%], abdominal pain(62.0%) which was more significant as compared to other 
studies listed below. 
 Fever (74.0%), Hepatomegaly (32.0%) was common presentation in our 
series and was comparable to the studies listed below but icterus (32.0%) was more 
common clinical presentation compared to study done by Hyo Min Yoo et al (7.0%) 
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 SYMPTOMS Hyo   Min Khee   Siang, Shyam Present Series
  Yoo et al60 Ching Ming Mathur  
       
 Pain in Abdomen 85.0% 57.0% 80.0% 62.0% 
       
 Fever 71% 97.2% 70.0% 94.0% 
       
       
 SIGNS      
       
       
       
 Hepatomegaly 41.0% -  - 32.0% 
       
 Icterus 7.0% -  - 76.0% 
       
ALCOHOLISM IN CASES OF LIVER ABSCESS   
     
Study   Alcoholism  
      
Shyam Mathur et al   70%   
      
Present Series   70.0%   
        
 
 
Alcoholism was found to be the most consistent etiological factor in this study 
of liver abscess. 70% of the cases of this study were found to be alcoholics as 
compared to other study by Shyam Mathur et al where 70% of the cases were 
alcoholic which concludes Alcoholism has a strong association with liver abscess 
patients. 
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ANALYSIS OF LABORATORY  
 
INVESTIGATIONS 
 
Labarotary Investigations Hyo Min Yoo et al Present Series 
   
    
Alkaline Phosphatase 55% 36.0% 
(>115 IU/L)    
   
Albumin (<3.0gm/dl) 68% 12.0% 
    
Prothrombin Time  (>20 14% 14.0% 
sec)    
    
 
 
 The above table shows that following Lab. Investigations Raised Alkaline 
Phosphatase, Raised GGT was found in most of Alcoholic liver abscess patients. 
Hypoalbuminaemia, Raised Prothrombin Time are the most important Laboratory 
Investigations in Diagnosing Liver Abscess. 
 Present series showed trends similar to those of other study listed above 
but Raised Alkaline Phosphatase Levels was the single most common Labarotory 
abnormality in our study for Diagnosis of Liver abscess. 
 
 
USG FINDINGS OF LIVER ABSCESS 
 
      Chaturbhul World J    
 
     Hyo Min Lal Rajak Gastroenterol  Present    Lobar Distribution   et al
65
  2008 April 7;     Yoo et al     Series            14(13): 2089-                 
 
       2093    
 
            
 
 Solitary abscess 89.0% 84.0% 76.29% 76.0%  
 
           
 
   Right lobe abscess 69.0% 72.0% 74.12% 70.0%              
 
           
 
   Left lobe abscess 20.0% 12.0% 14.28% 14.0%              
 
         
 
 Multiple abscess 11.0% 20.0% 23.7% 24.0%  
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 Size of liver abscess        
 
 (cms)          
 
           
 
   <5cms 45.0% - 34.16% 32.0%              
 
           
 
   >5cms 55.0% - 65.83% 68.0%              
 
              
 
 
 
Ultrasound abdomen was done to all patients in this study and various findings 
were analysed. 
Solitary abscess was seen in 76.0% of cases & Multiple abscesses were seen in 
24.0% cases comparable to other Studies 
Right lobe involvement (70.0%) was comparable to other studies listed above 
but isolated left lobe involvement was 14% in our study as compared to other study 
Hyo Min Yoo et al (11.0%) and Chaturbhul Lal Rajak et al (20.0%) & World J 
Gastroenterol 2008 April 7; 14(13): 2089-2093 (23.7%) 
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ANALYSIS OF TREATMENT  
 
Treatment Modality Hyo Min Yoo et al Present Series 
   
Surgical 21.0% 14.0% 
Open Laparotomy 21.0% 14.0% 
   
   Aspiration 79.0%      - 
Pigtail Catheter Drainage - 52.0% 
   
Conservative  (Antibiotics - 34.0% 
Only)   
   
 
 
Controversies in the management of liver abscess still exist. Surgical drainage 
of liver abscess has been an accepted therapy for decades. The diagnosis and 
treatment of liver abscess has changed due to advances in imaging techniques. 
7/50 Patients (14%) underwent laparotomy compared to 21.0% Hyo Min et al 
study. 
26/50 patients (52.0%) underwent pigtail catheter drainage under ultrasound 
guided compared to Hyo Min et al study no patient underwent pigtail drainage. 
17/50 patients (34.0%) whose abscess size was <5ml underwent conservative 
(medical)  management compared to Hyo Min et al study no concept of conservative 
management. 
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CONCLUSION 
 
Liver abscess is a very common condition in India. India has 2nd highest incidence of 
liver abscess in world. 
 Liver abscesses occurred most commonly between 30-60 years 
 
 Most of the cases had an acute presentation 
 
 Males were affected more than females. 
 
 Pain abdomen was the most consistent symptom 
 
 Fever being the most common occurring symptom 
 
 Alcohol consumption was the single most important etiological factor for causation of 
liver abscesses. 
 Alkaline phosphatase is the most consistently elevated among all Liver Function 
Tests. 
 Raised Alkaline phosphatise level, Raised SGOT,SGPT,GGT, Hypoalbuminaemia, 
Prolonged Prothrombin time were considered as the predictive factors of complicated 
(Ruptured) liver abscess in this study.. 
 Liver abscess usually present as a solitary abscess most commonly in the right lobe of 
liver. 
 All cases of liver abscesses do not require invasive management. 
 
 Multiple small abscesses and solitary abscess of volume < 5cm can be managed 
successfully on conservative antimicrobial therapy alone but recurrence rate was high. 
 Ultrasound Guided  Pig Tail Catheter drainage procedure is a safe and effective 
method of liver abscess management in  abscesess size >5cm unrupturred. 
 Laparotomy and Drainage  remains the standard of care in ruptured liver abscess into 
the peritoneal cavity in this study, as we had no recurrence and mortality associated 
with it. 
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SUMMARY 
 
 
 
A clinical study of liver abscesses was chosen as this is a fairly commonly 
disease in this part of the country. An attempt was made in this study to define the 
various symptom complex, modes of presentation, methods used in diagnosis, 
treatment options of liver abscesses.  
 
The following observations were made in the present study: 
 
 Mean age of preseFever being the most commonly occurring symptom in 
74.0% of cases. 
 
Fever being the most commonly occurring symptom in 74.0% of cases. 
 Pain abdomen was the most consistently occurring symptom present in 62%cases  
 
  Hepatomegaly was present in 32% of cases, icterus was found in 76% of the cases, 
 This study found the Alcohol as the single most consistent etiological factor in 
all patients of liver abscess. 70.0% of cases consumed alcohol. Thus it may seem 
likely that alcoholism may predispose to formation of liver abscesses. 
 
    Laboratory investigations were analysed.  Alkaline phosphatase (64%) 
was the single most consistent liver function test to be abnormal in cases of liver 
abscesses. Hypoalbuminemia was noted in 12% of cases, Prolonged Prothrombin time 
(>20 sec) in 14% cases and raised SGOT (28%) & SGPT (26%), GGT (66%). 
 
    Alkaline phosphatase level (>300 IU/l), Hypoalbuminaemia 
(<3.0mg/dl), Prolonged Prothrombin time (>20 sec) were considered as the predictive 
factors of complicated (Ruptured) liver abscess in our study. 
 
    Ultrasonography revealed solitary abscess in 76.0% and multiple 
abscesses in 24.0%. Isolated right lobe abscess was seen in 70.0% and left lobe 
abscess in 14%. Both lobe involvement was seen in 16.0% of cases. Number of cases 
with abscess volume  size <5cms was 32% and those with size >5cms was 68%. 
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    Out of the total 50 cases in this study, cases who had multiple small abscesses 
and solitary abscesses < 5ml were managed conservatively. 17/50 (34.0%) were 
managed conservatively. 
 
  While 26/50(52.0%) cases underwent Pig-Tail Catheter Drainage 
  Rest 7/50 (14.0%) required Laparotomy and Drainage and  for ruptured liver abscess. 
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INFORMATION SHEET 
 
We are conducting a study on  “ CLINICAL STUDY OF LIVER ABSCESS ” 
among patients attending Rajiv Gandhi Government General Hospital, Chennai  
 
The purpose of this study is to assess  
 
We are selecting certain cases and if you are found eligible, we may be using 
clinical profile, lab test reports and radiological reports for study purposes which does 
not affect your final report or management. 
 
The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result in 
any loss of benefits to which you are otherwise entitled. 
 
The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
 
Signature of Investigator   Signature of Participant / Guardian 
 
 
 
Date : 
Place: 

PATIENT CONSENT FORM 
 
Study Detail :  
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification Number :  
Patient may check (☑) these boxes 
The details of the study have been provided to me in writing and explained 
to me in my own language ❏ 
I understand that my participation in the study is voluntary and that I am free 
to withdraw at any time without giving reason, without my legal rights being 
affected. ❏ 
I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities will 
not need my permission to look at my health records, both in respect of 
current study and any further research that may be conducted in relation 
to it, even if I withdraw from the study I agree to this access. However, I 
understand that my identity will not be revealed in any information 
released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from this 
study. ❏ 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms. ❏ 
I hereby consent to participate in this study. ❏ 
I hereby give permission to undergo complete clinical examination , 
biochemical and radiological tests ❏ 
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PROFORMA 
 
NAME OF THE PATIENT  : 
AGE / SEX  : 
IP/OP NUMBER  : 
OCCUPATION  : 
ADDRESS  : 
CONTACT NUMBER  : 
CARE GIVER                              : 
 
CHIEF COMPLAINTS: 
 
PRESENTING ILLNESS: 
1. JAUNDICE  : 
2. ABDOMINAL DISTENSION : 
3. ABDOMINAL PAIN : 
4. FEVER : 
5. ALTERED SENSORIUM : 
6. BLEEDING MANIFESTATION : 
7. VOMITING : 
8. LOSS OF WEIGHT :  
 
 
PAST HISTORY:      
1. DIABETES MELLITUS  : 
2. SYSTEMIC HYPERTENSION   : 
3. CHRONIC KIDNEY DISEASE  : 
4. CORONARY ARTERY DISEASE  : 
5. HYPOTHYROIDISM  : 
6. SEIZURE DISORDER  : 
7. TRAUMA  : 
 
      TREATMENT HISTORY:                                                                                        
1. ANTIEPILEPTIC THERAPY : 
2. ANTIRETROVIRAL THERAPY : 
3. TREATMENT FOR CIRRHOSIS : 
4. VASOPRESSIN THERAPY : 
 
PERSONAL HISTORY:    
SMOKING    :    
ALCOHOL   : 
TEMPERATURE    : 
PULSE RATE   : 
BLOOD PRESSURE   : 
 
 
SYSTEMIC EXAMINATION:   
CVS   : 
RS  : 
ABDOMEN  : 
CNS  : 
INVESTIGATIONS: 
WBC  : 
HB  : 
HCT  : 
PLATELET  :  
SERUM UREA  : 
SERUM CREATININE  : 
TOTAL BILRUBIN  : 
DIRECT BILRUBIN  : 
SGOT  : 
SGPT  : 
GGT                                   : 
ALT  : 
SERUM PROTIEN  : 
SERUM ALBUMIN  : 
PROTHROMBIN TIME    : 
USG ABDOMEN  : 
 
 
 
 
 
  
 
KEY TO MASTER CHART 
 
 
- -  Absent 
 
+ -  Present 
 
ALP  -  Alkaline Phosphatase 
 
R                      -   Right lobe 
 
    L                     -   Left lobe 
 
B  -  Both lobes 
 
Hb  -  Hemoglobin 
 
PT  -  Prothrombin time 
 
SGOT              -  Serum glutamic-oxaloacetic transaminase 
 
SGOT              -  Serum glutamic-pyruvic transaminase 
 
GGT                - Gama glutamyl transferrase 
 
S.Albumin       -  Serum Albumin 
 
 
MASTER CHART
S.NO NAME AGE SEX
ABDOMINAL 
PAIN FEVER ALCHOLISM ICTERUS
HEPATOM
EGALY HB% WBC BILIRUBIN ALP RAISED
S.ALBUMIN 
(<3MG/ML)
SGOT 
(>40IU/ML)
SGPT 
(>40IU/ML)
GGT 
(>30IU/L) PT(>20SEC)
LOBE            
INVOLVED
SINGLE/ 
MULTIPLE SIZE(CM) TREATMENT
1 KUPPUSAMY 54 M + + + - NO 10.4 14000 0.5 NO NO YES NO YES NO R S <5 CONSERVATIVE
2 RAJA 25 M + + - - NO 11 13700 0.2 NO NO YES NO NO YES R S >5 PIGTAIL DRAINAGE
3 VINAYAGAM 51 M - - + - NO 11.8 8600 0.7 NO NO NO NO YES NO R S <5 CONSERVATIVE
4 MANIVEL 44 M + + + + YES 12.2 13100 4.5 NO NO YES YES YES NO R M >5 LAPARATOMY
5 FAZHIL 56 M - + + - NO 10.3 11500 0.5 YES NO NO NO YES NO L S >5 PIGTAIL DRAINAGE
6 VETRI 35 M + + + - YES 10.8 13000 0.6 NO NO NO NO YES NO R S <5 CONSERVATIVE
7 HARI 28 M + + + - YES 10.5 14800 0.3 NO NO NO NO YES YES R S >5 PIGTAIL DRAINAGE
8 RANGANATHAN 47 M - + - + NO 7.8 7000 5.2 YES NO YES NO NO NO R M >5 LAPARATOMY
9 SAMYKANNU 55 M + - + - NO 10.6 12300 0.6 NO NO NO NO YES NO L S <5 CONSERVATIVE
10 VIVEKANANDHAN 45 M + + + - YES 10.5 10700 0.7 NO NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
11 GOVINDASAMY 68 M - + - - NO 10.2 1130 0.6 NO NO NO NO YES NO R S <5 CONSERVATIVE
12 RAJKAMAL 43 M + + + + NO 10.2 12300 4.8 NO NO YES YES YES NO B M >5 LAPARATOMY
13 AMUL 46 F - + - - YES 10.1 12500 0.7 YES NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
14 KALAIYARASAN 53 M + + + - NO 10.7 13100 0.8 NO NO NO NO YES NO L S <5 CONSERVATIVE
15 NARAYANAN 42 M - - + - NO 10.5 14200 1.9 NO YES NO YES YES YES B M >5 PIGTAIL DRAINAGE
16 KARTHICK 38 M + + + - NO 11.3 13400 0.5 YES NO NO NO YES NO R S >5 PIGTAIL DRAINAGE
17 RENUKA 55 F - + - - NO 11.7 12500 0.8 NO NO NO NO NO NO L S <5 CONSERVATIVE
18 KANNISAMY 46 M + + + - YES 11.1 15400 0.8 YES NO NO YES YES NO R M >5 LAPARATOMY
19 JOTHY 36 F + + - - NO 7.8 12800 0.7 YES NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
20 STALIN 45 M - - + - NO 10.7 13000 0.7 YES NO NO YES YES NO R S <5 CONSERVATIVE
21 BASHA 32 M + + + - YES 10.1 11200 0.3 YES NO NO NO YES NO R S <5 CONSERVATIVE
22 RAJA 42 M - + - + NO 10.4 12500 4.2 NO NO YES YES NO NO R M >5 LAPARATOMY
23 THAMSEEN 55 M + - + - NO 9.6 13000 0.6 YES YES NO NO YES NO R S >5 PIGTAIL DRAINAGE
24 PONNAIYAN 35 M - - + - YES 11.2 12400 1.6 YES YES NO NO YES NO R S <5 CONSERVATIVE
25 DHANASEKAR 24 M + + + - NO 11 11000 0.4 NO NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
26 ANBARASI 35 F + + - - YES 10.6 8000 0.4 NO NO NO NO NO NO R S >5 LAPARATOMY
27 VIJAY 23 M + - + - NO 10.3 12800 0.7 NO NO NO NO YES NO L S <5 CONSERVATIVE
28 MUNIYAN 46 M - + + + NO 10.7 19000 7.4 YES NO YES YES YES YES B M >5 PIGTAIL DRAINAGE
29 KATHAMUTHU 49 M + - + - NO 9.1 10500 0.4 NO NO NO NO YES NO R S >5 PIGTAIL DRAINAGE
30 LANKARAM 39 M - + + + YES 10.8 11000 2.1 NO NO YES YES YES YES B M >5 PIGTAIL DRAINAGE
31 RAJESH 48 M + - + - NO 11.4 13400 0.5 YES NO NO NO YES NO R S <5 CONSERVATIVE
32 PRATHAP 36 M - + - - YES 10.7 13100 0.6 NO YES NO NO NO NO R S <5 CONSERVATIVE
33 SURYA 55 M + + + - NO 11.5 12700 0.3 NO NO NO NO YES NO R S >5 PIGTAIL DRAINAGE
34 MATHIALAGAN 45 M + - + + NO 11.3 12500 2.5 NO NO YES YES YES NO B M >5 LAPARATOMY
35 BABU 37 M + + - - YES 10.5 13000 0.5 YES NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
36 NOOR BASHA 32 M - + - - NO 10.8 13400 0.6 NO NO NO NO NO YES R S >5 PIGTAIL DRAINAGE
37 SENTHIL 26 M + + + + NO 10.3 9000 2.8 YES YES YES YES YES NO B M >5 PIGTAIL DRAINAGE
38 MOHAN 48 M - + - - YES 10.6 10700 0.5 YES NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
39 ANTONY 33 M + + + - NO 10.1 12800 0.6 NO NO NO NO NO YES R S >5 CONSERVATIVE
40 PONMANI 27 F - + - + NO 9.6 12600 2.7 NO YES YES YES NO NO B M >5 PIGTAIL DRAINAGE
41 RAMKUMAR 45 M - + + - NO 10.2 13400 0.8 NO NO NO NO YES NO R S <5 CONSERVATIVE
42 DANDAPANI 37 M + + + - YES 10.6 7000 0.8 NO NO NO NO YES NO L S >5 PIGTAIL DRAINAGE
43 SAKTHIVEL 46 M + + + + NO 8.6 13500 2.3 YES NO YES YES YES NO R S >5 PIGTAIL DRAINAGE
44 KARIYAN 58 M + - + - NO 9.2 14300 0.7 NO NO NO NO YES NO R S >5 PIGTAIL DRAINAGE
45 RAMESH 18 M - + + + YES 11.4 12700 3.3 NO NO NO NO YES NO R S <5 CONSERVATIVE
46 CHANDRU 35 M + + - - NO 10.4 11300 0.4 NO NO NO NO NO NO R S >5 PIGTAIL DRAINAGE
47 ARIUDAINAMBI 43 M + - + + YES 10.7 13800 2.9 YES NO YES YES YES NO B M >5 PIGTAIL DRAINAGE
48 VELMURUGAN 28 M + - + - NO 11.5 13500 0.5 NO NO NO NO YES NO R S <5 CONSERVATIVE
49 SIVARUBAN 58 M - + - - NO 11.3 9000 0.7 NO NO YES NO NO NO L S >5 PIGTAIL DRAINAGE
50 JANA 36 M + + + - NO 10.4 12300 0.5 YES NO NO NO YES NO R S >5 PIGTAIL DRAINAGE
